Detection of cancer‐associated cachexia in lung cancer patients using whole‐body [18F]FDG‐PET/CT imaging: A multi‐centre study

Abstract Background Cancer‐associated cachexia (CAC) is a metabolic syndrome contributing to therapy resistance and mortality in lung cancer patients (LCP). CAC is typically defined using clinical non‐imaging criteria. Given the metabolic underpinnings of CAC and the ability of [18F]fluoro‐2‐deoxy‐D...

Description complète

Détails bibliographiques

Auteurs principaux:	Daria Ferrara, Elisabetta M. Abenavoli, Thomas Beyer, Stefan Gruenert, Marcus Hacker, Swen Hesse, Lukas Hofmann, Smilla Pusitz, Michael Rullmann, Osama Sabri, Roberto Sciagrà, Lalith Kumar Shiyam Sundar, Anke Tönjes, Hubert Wirtz, Josef Yu, Armin Frille
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2024-12-01
Collection:	Journal of Cachexia, Sarcopenia and Muscle
Sujets:	[18F]Fluoro‐2‐deoxy‐D‐glucose Cachexia Lung cancer Metabolism PET/CT
Accès en ligne:	https://doi.org/10.1002/jcsm.13571
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!